Ewing's Sarcoma: Difference between revisions

No edit summary
No edit summary
 
(46 intermediate revisions by 9 users not shown)
Line 4: Line 4:
'''Top Contributors''' - {{Special:Contributors/{{FULLPAGENAME}}}}    
'''Top Contributors''' - {{Special:Contributors/{{FULLPAGENAME}}}}    
</div>  
</div>  
== Definition/Description<br> ==
== Introduction ==
[[File:Ewing-sarcoma-distal-femur.jpeg|thumb|Ewing-sarcoma-distal-femur]]
Ewing’s Sarcoma (ES) is the second highest grade malignant primary tumour of childhood and adolescence between 10-20 years of age, and can arise in soft tissue or bone. <ref name="p1">Paulussen, Michael. Frohlich, Brigit, Jurgens, Herbert. [https://link.springer.com/article/10.2165%2F00128072-200103120-00003 Ewing Tumour: Incidence, Prognosis, and Treatment Options]. Pediatric Drugs 2001; 3(12); 899-913.(accessed 28 Feb 2011).</ref> ESs typically are found in the medullary cavity, appearing as moth-eaten, destructive lesions in the shaft of long bones, and onion skin periostitis.<ref name=":0">Radiopedia [https://radiopaedia.org/articles/ewing-sarcoma?lang=gb Ewing sarcoma] Available:https://radiopaedia.org/articles/ewing-sarcoma?lang=gb (accessed 27.12.2023) </ref> The most common sites are the pelvis, axial skeleton, and femur, but they may occur in almost any bone or soft tissue. Patients with ES within distal extremities have a better prognosis than patients having a lesion in proximal extremities.<ref name=":1">Durer S, Shaikh H. [https://www.ncbi.nlm.nih.gov/books/NBK559183/ Ewing sarcoma].Available: https://www.ncbi.nlm.nih.gov/books/NBK559183/<nowiki/>(accessed 267.1.2023)</ref>


Ewing’s Sarcoma is a high grade malignant primary tumor that can arise in soft tissue or bone. The tumor is named after James Ewing who first discovered the small, blue round cell that was distinctly different from osteogenic sarcoma<ref name="1">Paulussen, Michael. Frohlich, Brigit, Jurgens, Herbert. Ewing Tumour: Incidence, Prognosis, and Treatment Options. Pediatric Drugs 2001; 3(12); 899-913. http://www.ncbi.nlm.nih.gov/pubmed/11772151 (accessed 28 Feb 2011).</ref>. &nbsp;It is often referred to as a family of tumors known as Ewing family of tumors (EFT)<ref name="1" /><ref name="2">Goodman, Boissonnault, Fuller. Pathology: Implications for the Physical Therapist. Pennsylvania: Saunders, 2003.</ref><ref name="3">Medline Plus. Ewing’s Sarcoma. http://www.nlm.nih.gov/medlineplus/ency/article/001302.htm (accessed Feb 2011).</ref>&nbsp;<ref name="4">Grimer, Robert, Athanasou, Nick, Gerrand, Craig, Judson, Ian, Lewis, Ian, Morland, Bruce, Peake, David, Seddon, Beatrice, Whelan, Jereamy. UK Guidelines for the Management of Bone Sarcomas. Sarcoma 2010; 1-14.</ref>The Ewing family of tumors include Ewing’s Sarcoma, Extraosseous Ewing Sarcoma, Askin Tumor, and Primitive Neuroectodermal Tumor. Although any bone can be involved, the most common are the pelvis, hip, femur, tibia and fibula <ref name="5">Elaine Lonnemann’s Powerpoint, Oncology. Pathophysiology of Complex Patient Problems. Bellarmine University 2011.</ref>.&nbsp;Less common sites include the ribs and vertebral column<ref name="4" /> &nbsp;.&nbsp;The most common sites for secondary tumors include the lungs, bone marrow and other bones; rarely does Ewing’s Sarcoma metastasize to the lymphatic system, brain or liver.&nbsp;<ref name="6">Ewing sarcoma. Bone Cancer Research Trust. https://www.bcrt.org.uk/information/information-by-type/ewing-sarcoma/. Accessed April 5, 2017.</ref>
'''Locations''':


<br>  
# Lower limbs: 45%(femur most common)
# Pelvis: 20%
# Upper limbs: 13%
# Spine and ribs: 13%(sacrococcygeal)
# Skull/face: 2%<ref name="p6">[https://www.bcrt.org.uk/information/information-by-type/ewing-sarcoma/ Ewing sarcoma. Bone Cancer Research Trust].  Accessed April 5, 2017.</ref>.


[[Image:Ewings 2.jpg|left|250px]][[Image:Ewings 1.jpg|center|250px|Bone Cancer Research Trust]]<ref name="6" /><br>
== Epidemiolgy ==
[[Image:Ewings 3.png|222x222px|right|alt=]]Ewing sarcoma account for less than 5% of all soft tissue sarcomas.<ref name=":1" />  ES usually appears in children and adolescents between 10-20 years of age (with 95% being between 4-25 years of age).Males are more affected than females (M:F 1.5:1).<ref name=":0" /> The ES family of tumours primarily occurs in White patients. In the United States, the incidence in the Asian/Pacific Islander population is about one-half that in the White population, while the incidence in the Black population is one-ninth that in White population. <ref name="p7">Burningham Z, Hashibe M, Spector L, Schiffman JD. [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564705/ The epidemiology of sarcoma]. Clinical sarcoma research. 2012 Dec 1;2(1):14.</ref> The incidence of Ewing’s Sarcoma has relatively been unchanged for the past 30 years and occurs  2.93 children per 1 million in the United States. <ref name="p0">Ewing’s SarcomaTreatment. National Cancer Institute. https://www.cancer.gov/types/bone/hp/ewing-treatment-pdq#link/_153_toc.</ref>.
== Etiology ==


== Prevelance  ==
The cell of origin of Ewing sarcoma has yet to be fully explained<ref name=":1" />. It has been found that 95% of Ewing's tumours are derived from a specific reciprocal translocation between chromosomes 11 and 22. The molecular oncogenesis remains unknown<ref name="p2">Goodman, Boissonnault, Fuller. Pathology: Implications for the Physical Therapist. Pennsylvania: Saunders, 2003.</ref><ref name="p1" />.
 
== Prognosis ==
Ewing’s Sarcoma primarily affects Caucasians, whereas Asian and African populations are considerably less affected.<ref name="7">Burningham Z, Hashibe M, Spector L, Schiffman JD. The Epidemiology of Sarcoma. Clinical Sarcoma Research. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564705/. Published 2012.</ref> Rates of Ewing’s Sarcoma are found to be higher in North America as compared to Europe or Asia. The rate of prevalence between males and females is not significantly different. Ewing’s Sarcoma is not currently related to any gene mutations or hereditary cancer syndromes. However, relationships between race and inherited familial risk suggests a possible association<ref name="7" />. Ewing's Sarcoma is the second most common primary malignant bone tumor of children and the fourth most common overall. 80% of these tumors occur in people under the age of 20. EFT is most common in children between the ages of 5 and 16. Factors include a tall stature or experiencing a premature growth spurt from puberty. In adults risk factors such as infection, radiation, and occupation increase the risk of development of Ewing’s Sarcoma.<ref name="7" /><br>
 
<br>
 
[[Image:Ewings 3.png|center|250x200px]]<br>
 
<br>
 
*Youngest reported case of EFT&nbsp;-&nbsp;5 months old&nbsp;
*Oldest&nbsp;reported case&nbsp;- 77 year old female<br>
*More common in males than females 1.5:1<ref name="1" />&nbsp;<ref name="2" /><ref name="3" /><ref name="4" /><ref name="8">Goodman C, Snyder T. Differential Diagnosis for Physical Therapists: Screening for Referral. St. Louis, MO: Saunders Elsevier: 2007</ref><ref name="9">Karosas, Ann O. Ewing’s sarcoma. Am J Health-Syst Pharm 2010; 67; 1599-1605. http://www.ajhp.org/content/67/19/1599.full.pdf+html (accessed 28 Feb 2011).</ref>
 
&nbsp; &nbsp;
 
<br>
 
== Incidence<br>  ==
 
The incidence of Ewing’s Sarcoma has relatively been unchanged for the past 30 years, and occurs 1 per 1 million people in the United States. Currently in the United States, the incidence rate is currently nine fold greater in Caucasian males and females than in African Americans, and intermediate recurrence in Asian Americans. <ref name="10">Ewing’s SarcomaTreatment. National Cancer Institute. https://www.cancer.gov/types/bone/hp/ewing-treatment-pdq#link/_153_toc.</ref><br>
 
<br>
 
== Prognosis<br>  ==
 
Ewing’s sarcoma is typically cured 70% of the time in the early stages of metastasis. Teenagers in the range of 15-19 have a lower survival rate of 56%.<ref name="11">Ewings Sarcoma. St. Jude Children's Research Hospital. https://www.stjude.org/disease/ewing-sarcoma.html.</ref> &nbsp;After the disease has spread, children have a survival rate of less than 30%.<ref name="11" /> <br>
 
<br>
 
== Etiology/Causes  ==
 
It has been found that 95% of Ewing's tumors are derived from a specific genetic translocation between chromosomes 11 and 22. The molecular oncogenesis remains unknown.<ref name="2" /><ref name="1" /><ref name="12">American Academy of Orthopaedic Surgeons. Ewing’s Sarcoma. http://orthoinfor.aaos.org/topic.cfm?topic=a00082 (accessed 28 Feb 2011).</ref>


Once a uniformly fatal tumour now has better survival rates, although these differ with location. eg Spinal tumours having an 86% long-term survival compared to 25% of sacrococcygeal tumours. Overall the 5-year survival rate is roughly  50-75% for patients with local disease only at the time of presentation.<ref name=":0" />
== Characteristics/Clinical Presentation  ==
== Characteristics/Clinical Presentation  ==
[[Image:Ewings 5.png|alt=|thumb|Occasionally a soft tissue mass is palpable]]Local pain at the affected site is usually the initial symptom<ref name="p1" />.&nbsp;The [[Pain-Modulation|pain]] may be worse during exercise or at night and can be accompanied by swelling or a lump, redness, and warmth (see in this picture swelling of the left side)<ref name="p3">Medline Plus. Ewing’s Sarcoma. http://www.nlm.nih.gov/medlineplus/ency/article/001302.htm (accessed Feb 2011).</ref>.&nbsp;The pain is typically intermittent and ma progress to be more consistent.<ref name="p5">Elaine Lonnemann’s Powerpoint, [https://soar.usa.edu/dissertations/5/ Oncology. Pathophysiology of Complex Patient Problems]. Bellarmine University 2011.</ref>&nbsp;Tumours that are deep inside the body such as the pelvis can be hidden from observation and inspection. 


Local pain at the affected site is usually the initial symptom<ref name="1" />&nbsp;.&nbsp;The pain may be worse during exercise or at night and can be accompanied by swelling or a lump, redness, and warmth (see picture below)<ref name="13">Kids Health from Nemours. Ewing Sarcoma. http://kidshealth.org/parent/medical/cancer/ewings.html (accessed 28 Feb 2011).</ref>.&nbsp;The pain is typically intermittent.<ref name="5" />&nbsp;Tumors that are deep inside the body such as the pelvis can be hidden from observation and inspection. <br>
It is common to see [[Fatigue Severity Scale|fatigue]], weight loss, decreased appetite, weakness and numbness, and/or paralysis or [[Urinary Incontinence]] (if the tumour is of spinal origin)<ref name="p4">Gerrand C, Athanasou N, Brennan B, Grimer R, Judson I, Morland B, Peake D, Seddon B, Whelan J. [https://link.springer.com/article/10.1186/s13569-016-0047-1 UK guidelines for the management of bone sarcomas. Clinical Sarcoma Research]. 2016 Dec 1;6(1):7.</ref>. [[Fever]], [[anaemia]], and leukocytosis may occur with this tumour and a palpable mass may present. The tumour may be present for months before there are any signs or symptoms. Symptoms can vary from patient to patient in terms of severity and can disappear from weeks to months at a time<ref name="p6" /> [[Insufficiency Fracture|Insufficiency Fractures]] also occur.<ref name="p2" />. Systemic symptoms include ESR elevation. Ewing's Family of Tumors are highly malignant. It most commonly spreads to the lungs, but it can also metastasize to the kidney, bone marrow, heart, adrenal gland, and other soft tissues<ref name="p4" />.<br>As a physical therapist, one should be cautious when the symptoms of "growing pains" or a proposed sports injury are out of proportion or abnormal.
 
[[Image:Ewings 5.png|left]]<br>
 
<br>
 
[[Image:Ewings 5|left]]<br>
 
<br>
 
<br>
 
<br>
 
[[Image:Ewings 4.png|left]]
 
<br>
 
<br>
 
<br>
 
<br>
 
<br>
 
<br>
 
<br>
 
<br>
 
<br>
 
<br>
 
<br>
 
<br>
 
<ref name="5" /><br>
 
<br>
 
<br>
 
It is common to see fatigue, weight loss, decreased appetite, and/or paralysis or incontinence (if the tumor is of spinal origin)<ref name="14">Children’s Hospital Boston. Ewing’sSarcoma. http://www.childrenshospital.org/az/Site852/mainpageS852P0.html (accessed March 2011)</ref>&nbsp;.The tumor may be present for months before there are any signs or symptoms. Symptoms can vary from patient to patient in terms of severity and can disappear from weeks to months at a time<ref name="6" />. &nbsp;An injury is often what brings attention to the tumor, this is due to progressive structural bone weakening by the disease, which can result in a fracture with minimal force. Children and adolescents with EFT can go undiagnosed until an injury from a sport or rough play requires diagnostic imaging&nbsp;.&nbsp;<ref name="12">American Academy of Orthopaedic Surgeons. Ewing’s Sarcoma. http://orthoinfor.aaos.org/topic.cfm?topic=a00082 (accessed 28 Feb 2011).</ref><br>As a physical therapist, one should be cautious when the symptoms of "growing pains" or a proposed sports injury are out of proportion or abnormal.<br>


== Differential Diagnosis  ==
== Differential Diagnosis  ==


Osteomyelitis and Ewing's Sarcoma may both present with swelling, redness, low grade fever, and flu-like symptoms. The patient will typically experience intermittent pain with Ewing's Sarcoma versus the constant pain seen with osteomyelitis<ref name="5" />. The patient may also experience extreme fatigue, weight loss, and loss of appetite with a tumor. Antibiotics will not affect Ewing's Sarcoma, but should help with osteomyelitis. X-rays and Lab values are utilized to distinguish Ewing’s Sarcoma and Osteomyelitis. Ewing’s Sarcoma’s symptoms are very general and a differential diagnosis of this condition include tendonitis, Osgood Schlatter disease, trauma, and slipped epiphysis of a long bone<ref name="6" />.&nbsp;<br>Review an excellent Presentation on Ewings Sarcoma by Jen Son and Gilian Lieberman MD<br>
* [[Osteomyelitis]]
 
* [[Osteosarcoma]]
<span>http://eutils.ncbi.nlm.nih.gov/entrez/eutils/erss.cgi?rss_guid=1VsHRGSo3HX0CgCh0yQTDe7FwEqMdcz0ZoLhJtVqvvv0fjjM7M|charset=UTF-8|short|max=10</span><br>
* Metastatic disease
 
* Haematological malignancy
<br>
* Eosinophilic granuloma
 
* [[Neuroblastoma]]<ref name=":0" />
== Systemic Involvement  ==
== Diagnosis ==
 
[[File:Ewing-sarcoma.jpeg|thumb|Periostitis and soft tissue swelling.]]
Ewing's Family of Tumors are highly malignant. It most commonly spreads to the lungs, but it can also metastasize to the kidney, bone marrow, heart, adrenal gland, and other soft tissues.Chemotherapy and radiation, which are most commonly used to treat EFT, have many systemic side effects including hair loss, nausea, vomiting, ulcers, and low blood cell count.&nbsp;<br>
The diagnosing Ewing’s Sarcoma depends on full patient history, symptoms and clinical presentation. X-rays of the affected area may show destructive confluent <nowiki>''</nowiki> moth-eaten" lesions, an elevated periosteum, or multilayered "onion-skin" periosteal reaction.  
 
== Diagnostic Tests/Lab Tests/Lab Values  ==
 
When diagnosing Ewing’s Sarcoma the first test most commonly used is X-Ray over the painful area. Other tests that may be performed to rule in Ewing’s Sarcoma and determine staging are: bone scans, CT scans, MRI, blood tests (elevated lactate dehydrogenase and red blood cell sedimentation rate) and biopsy. These tests in combination are important to find the location of the tumor and to determine if the tumor is localized or has diffused to other areas of the body to help guide treatment. Biopsy is considered the gold standard test for diagnosis of Ewing’s Sarcoma.<ref name="1" /><br>
 
<br>
 
&nbsp;
 
[[Image:Ewings 6.jpg|left]]<br>
 
[[Image:Ewings 7.jpg]]<br>


== Medical Management (current best evidence) ==
Other tests that may be performed to rule in Ewing’s Sarcoma and determine staging are bone scans, [[CT Scans|CT scans]], [[MRI Scans|MRI]], [[Blood Tests|blood tests]] (elevated lactate dehydrogenase and red blood cell sedimentation rate) and biopsy for bone marrow, for example, to know whether it spreads to bone marrow or not. These tests in combination are important to find the location of the tumour and to determine if the tumour is localized or has diffused to other areas of the body to help guide treatment. Biopsy is considered the gold standard test for diagnosis of Ewing’s Sarcoma.<ref name="p1" /><ref name="p5" /><ref name="p4" />


Depending upon location of the tumor and metastases, doctors in many specialties help treat EFT. Medical management is considered a multidisciplinary effort which includes orthopedic surgical oncologists, pediatric or adult medical oncologists, radiation oncologists, pathologists, and radiologists. Most patients are treated at major hospital institutions or cancer centers.<ref name="3" /><ref name="4" />&nbsp;<br>The first line of recommended treatment is chemotherapy, also referred to as cytostatic drug therapy, which is given through an indwelling intravenous catheter. Chemotherapy medications most commonly used are vincristine (Oncovin), dactinomycin (Actinomycin D), cyclophosphamide (Cytoxan), ifosfamide (Ifex), etoposide (VePeside, VP-16), and doxorubicin (Adriamycin)<ref name="4" />.&nbsp;Chemotherapy treatment is typically performed in cycles to let the blood cell count recover. The second line of treatment, which can be done before or during chemotherapy, is local treatment. Local treatment includes radiation and/or surgery. Surgery is used to treat the localized tumor when the tumor is easily assessable. When the localized tumor is not assessable as in the pelvis or spine, surgery is not an option and radiation is used to treat the localized tumor. A detrimental side effect that can result from radiation is structural deformities in children. Surgery can also be performed to rebuild a body part or limb. As the child grows, reconstruction therapy will be necessary to lengthen the bone.<ref name="3" /><ref name="4" /><br>Follow up intervals of 2-4 months for the first 3 years after completion of therapy are recommended for high-grade tumors such as EFT. Follow up every 6 months for year 4 and 5 and annually after that.Due to recent availability of multi-agent cytostatic approaches and local therapy, the 5 year survival rate has increased from 10% to 70%<ref name="4" />.<br>Immunological approaches, such as the use of cytokines (interleukins, and interferon), are still being researched.&nbsp;<br>  
== Differential Diagnosis ==
*[[Osteomyelitis]]
*[[Osteosarcoma]]
* Metastatic disease
* Haematological malignancy
* Eosinophilic granuloma
*[[Neuroblastoma]]<ref name=":0" />
== Medical Management ==
Systemic chemotherapy is the central part of treatment with surgery and/or radiotherapy having a role depending on the size and location of the tumour. Medical management is considered a multidisciplinary effort which includes orthopaedic surgical oncologists, pediatric or adult medical oncologists, radiation oncologists, pathologists, and radiologists. Most patients are treated at major hospital institutions or cancer centres.<ref>Bouaoud J, Temam S, Cozic N, Galmiche‐Rolland L, Belhous K, Kolb F, Bidault F, Bolle S, Dumont S, Laurence V, Plantaz D. [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308064/#cam41801-bib-0005 Ewing’s Sarcoma of the Head and Neck]: Margins are not just for surgeons. Cancer medicine. 2018 Dec;7(12):5879-88.</ref><ref name="p4" /><ref name="p1" /><ref name="p2" /><br>


<br>
== Physical Therapy Management  ==


== Physical Therapy Management (current best evidence) ==
Physical therapy (PT) can be beneficial for those diagnosed with ES for many reasons and at different stages during the management process. The most common limitations for patients undergoing chemotherapy include fatigue, paralysis, or weakness, cognition, and weight loss/ gain <ref name="p5" /><br>Pre-operative PT is beneficial when feasible. Plan of care should include strengthening of the affected limb and aerobic conditioning (precaution: avoid weight bearing on an extremity or placing weight distal to the extremity in which tumour is located).<ref name="p6" /><br>Post-operative PT is essential but caution must be taken because of the impaired healing process due to chemotherapy. Precautions include: stretching the skin in the area of the incision, weight-bearing status and lab values (especially platelet count). Some general guidelines include aerobic conditioning, strengthening, continuous passive range of motion, and aquatic therapy<ref name="p6" />. Research suggests that knowledge on the changes occurring in muscle architecture and its impact on long-term impairments in bone sarcoma survivors after limb salvage surgery can impact rehabilitation treatment outcomes<ref>Nelson CM, Marchese V, Rock K, Henshaw RM, Addison O. [https://pubmed.ncbi.nlm.nih.gov/32612962/ Alterations in muscle architecture: A review of the relevance to individuals after limb salvage surgery for bone sarcoma.] Frontiers in Pediatrics. 2020;8.</ref>.<br>If amputation is done, it may take the child several months to learn to use a prosthetic leg or arm. A physical therapist will be able to assist in fitting and donning the prosthesis, teaching the child how to use it, and how to use necessary assistive devices. Children may also have a tissue graft, which the child needs to start moving almost immediately. Physical therapy and rehabilitation is typically recommended for six to twelve weeks post operation<ref name="p2" />.


Physical therapy (PT) can be beneficial for those diagnosed with EFT for many reasons and at different stages during the management process. The most common limitations for patients undergoing chemotherapy include fatigue, paralysis, or weakness, cognition, and weight loss/ gain <ref name="5" />.<br>Pre-operative PT is beneficial when feasible. Plan of care should include strengthening of affected limb and aerobic conditioning (precaution: avoid weight bearing on extremity or placing weight distal to extremity in which tumor is located).<br>Post-operative PT is essential but caution must be taken because of the impaired healing process due to chemotherapy. Precautions include: stretching the skin in the area of incision, weight bearing status and lab values (especially platelet count). Some general guidelines include: aerobic conditioning, strengthening, continuous passive range of motion, and aquatic therapy.<br>If amputation is done, it may take the child several months to learn to use a prosthetic leg or arm. A physical therapist will be able to assist in fitting and donning the prosthesis, teaching the child how to use it, and how to use necessary assistive devices. Children may also have a tissue graft, which the child needs to start moving almost immediately. Physical therapy and rehabilitation is typically recommended for six to twelve weeks post operation.<br><br><span style="line-height: 1.5em;">&nbsp; &nbsp;&nbsp;</span><span style="line-height: 1.5em;">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp; </span>  
Watch this 2 minute video on PT management<br><span style="line-height: 1.5em;">&nbsp; &nbsp;&nbsp;</span><span style="line-height: 1.5em;">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp; </span>  


{{#ev:youtube|FRcrAieE_TA}}<br>
{{#ev:youtube|FRcrAieE_TA}}<ref>Joseph Dorrell. Physiopedia Ewing's Sarcoma PT Management. Available from: http://www.youtube.com/watch?v=FRcrAieE_TA[last accessed 25/7/2020]</ref>


= Ewing’s Sarcoma Case Study  =
== Ewing’s Sarcoma Case Study  ==


'''Keywords'''  
'''Keywords'''  


Fatigue, treatment, fever, bone pain, cancer, therapy, symptoms  
Fatigue, treatment, fever, bone pain, cancer, therapy, symptoms<br> '''Authors'''  
 
<br> '''Authors'''  
 
Jack Tencza and Joseph Dorrell
 
<br> '''Abstract'''
 
Ewing’s Sarcoma is the 2nd most commonly diagnosed form of primary bone cancer in children and young adults. In this example, a case study of an 18 year old Caucasian female gymnast is examined to help health care professionals identify a possible clinical case of Ewing’s Sarcoma.
 
<br> '''Introduction'''
 
Ewing’s Sarcoma family of tumors are a group of small round cell tumors that include Ewing’s Sarcoma, Extraosseous Ewing Sarcoma, Askin Tumor, and Primitive Neuroectodermal Tumor. This cancer primarily affects children and adolescents, and most often affects soft tissue and bone. The most common sites for Ewing’s Sarcoma is the pelvis, hip, femur, tibia and fibula.
 
== Case Presentation  ==


<u>Subjective&nbsp;:</u>  
Jack Tencza and Joseph Dorrell<br> '''Abstract'''


<br><u>Patient History:</u> Pt. is an 18 year old Caucasian female who reports with a recent history of right hip pain of 5/10 during the day and 7/10 at night. She reports limping from a cartwheel at gymnastics 2 months ago. She reports that she has had night sweats with intermittent fever and general fatigue during the day. Pt. reports that she has had a recent physical examination 5 months ago with her GP who found that she was underweight. GP states this could be possibly due to female athlete triad. She notes that she has been more attentive with her diet and exercise since then. Pt. states her goal is to return to gymnastics pain free and as soon as possible.  
Ewing’s Sarcoma is the 2nd most commonly diagnosed form of primary bone cancer in children and young adults. In this example, a case study of an 18 year old Caucasian female gymnast is examined to help health care professionals identify a possible clinical case of Ewing’s Sarcoma.<br> '''Introduction'''


<u>Medical History:</u> Unremarkable
Ewing’s Sarcoma family of tumours are a group of small round cell tumours that include Ewing’s Sarcoma, Extraosseous Ewing Sarcoma, Askin Tumor, and Primitive Neuroectodermal Tumor. This cancer primarily affects children and adolescents, and most often affects soft tissue and bone. The most common sites for Ewing’s Sarcoma is the pelvis, hip, femur, tibia and fibula.


<br><u>Objective&nbsp;: </u>Physical Examination Tests and Measures
==== Case Presentation  ====


<br>  
<u>Subjective&nbsp;:</u><br><u>Patient History:</u> Pt. is an 18-year old Caucasian female who reports with a recent history of right hip pain of 5/10 during the day and 7/10 at night. She reports limping from a cartwheel at gymnastics 2 months ago. She reports that she has had night sweats with intermittent fever and general fatigue during the day. Pt. reports that she has had a recent physical examination 5 months ago with her GP who found that she was underweight. GP states this could be possibly due to female athlete triad. She notes that she has been more attentive with her diet and exercise since then. Pt. states her goal is to return to gymnastics pain-free and as soon as possible.


<u>Observation/ Palpation:</u> Pt. has pinpoint tenderness around R ASIS, and notes pain with R weight shifting
<u>Medical History:</u> Unremarkable<br><u>Objective-: </u>Physical Examination Tests and Measures 


<br><u>Lumbar ROM</u><br>Lumbar Flexion 65<br>Lumbar Extension 35<br>Lumbar Sidebend 20<br>Lumbar Rotation 30  
<u>Observation/ Palpation:</u> Pt. has to pinpoint tenderness around R ASIS, and notes pain with R weight shifting<br><u>Lumbar ROM</u><br>Lumbar Flexion 65<br>Lumbar Extension 35<br>Lumbar Side bend 20<br>Lumbar Rotation 30


<u>Hip ROM Right Left</u><br>Hip Flexion &nbsp; &nbsp; 85 130<br>Hip Extension 15 30<br>Hip IR &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;20 40<br>Hip ER &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;25 40<br>Hip ABD &nbsp; &nbsp; &nbsp; 25 45  
<u>Hip ROM Right Left</u><br>Hip Flexion &nbsp; &nbsp; 85 130<br>Hip Extension 15 30<br>Hip IR &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;20 40<br>Hip ER &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;25 40<br>Hip ABD &nbsp; &nbsp; &nbsp; 25 45  
Line 170: Line 85:
<u>MMT</u><br>L Hip 5/5 in all planes<br>R Hip 4/5 in all planes (pain)<br>UE ROM: WNL<br>UE MMT: WNL  
<u>MMT</u><br>L Hip 5/5 in all planes<br>R Hip 4/5 in all planes (pain)<br>UE ROM: WNL<br>UE MMT: WNL  


<br><u>Neurovascular:</u> decreased sensation along R lateral thigh  
<br><u>Neurovascular:</u> decreased sensation along R lateral thigh<br><u>Special Tests:</u><br>FABER - Negative<br>Scour Test - Positive<br>Anterior Labral Tear - Negative<br>Impingement Test - Positive  
 
<br><u>Special Tests:</u><br>FABER - Negative<br>Scour Test - Positive<br>Anterior Labral Tear - Negative<br>Impingement Test - Positive  


'''Clinical Impression'''  
'''Clinical Impression'''  


Examination findings show decreased ROM and weakness of the R hip with palpable pinpoint pain, tenderness, and warmth. No other musculoskeletal abnormalities found to be present. Working diagnosis of female athlete triad and hip impingement. Targeted interventions include strengthening the R hip musculature, improving R hip ROM in all planes, manual therapy to decrease pain and improve function, and modalities for pain relief.  
Examination findings show decreased ROM and weakness of the R hip with palpable pinpoint pain, tenderness, and warmth. No other musculoskeletal abnormalities found to be present. Working diagnosis of female athlete triad and hip impingement. Targeted interventions include strengthening the R hip musculature, improving R hip ROM in all planes, manual therapy to decrease pain and improve function, and modalities for pain relief.  
<br>


'''Intervention'''  
'''Intervention'''  


Hip AROM/ PROM exercises<br>Standing hip flexion, extension, abduction, IR and ER resistance exercises<br>Wall slides &amp; standing squats<br>Hip long axis traction  
Hip AROM/ PROM exercises<br>Standing hip flexion, extension, abduction, IR and ER resistance exercises<br>Wall slides &amp; standing squats<br>Hip long axis traction<br>


<br>'''Outcomes'''  
'''Outcomes'''  


Over a period of 5 visits pt’s s/s did not improve. Pain intensified to a 7/10 during the day and an 8/10 at night. PT then determined that pt needed to be referred out for imaging of the hip. Pt went to MD and received X-Ray which indicated a possible tumor of the pelvis. Blood tests indicated elevated lactate dehydrogenase and red blood cell sedimentation rate. MD referred to Oncologist for biopsy which confirmed a Ewing’s Sarcoma of the pelvis. Pt received chemotherapy and radiation.  
Over a period of 5 visits, pt’s s/s did not improve. the Pain intensified to a 7/10 during the day and an 8/10 at night. PT then determined that pt needed to be referred out for imaging of the hip. Pt went to MD and received X-Ray which indicated a possible tumour of the pelvis. Blood tests indicated elevated lactate dehydrogenase and red blood cell sedimentation rate. MD referred to Oncologist for a biopsy which confirmed an Ewing’s Sarcoma of the pelvis. Pt received chemotherapy and radiation.  


<br>  
<br>'''Discussion'''


'''Discussion'''
Ewing’s Sarcoma is a malignant bone tumour which in this case affects a female, which is not as common as a male. In this case, the pt. demonstrated constitutional signs and symptoms including night sweats, weakness, fatigue, intermittent fever and increased pain at night which could indicate a systemic problem. Physical therapists should be aware that Ewing’s Sarcoma can mimic musculoskeletal signs and symptoms which can make it difficult to diagnosis. It is imperative to monitor the patient and refer out to patient’s MD when appropriate to prevent further metastasis of the tumour. The pelvic and hip region is the most common area affected by Ewing’s Sarcoma and can be difficult to observe and palpate due to its location. In this case the pt did not improve upon multiple visits which would indicate it is not a musculoskeletal pathology and the pt. was referred to her primary care provider for further testing.


Ewing’s Sarcoma is a malignant bone tumor which in this case affects a female, which is not as common as a male. In this case, the pt. demonstrated constitutional signs and symptoms including night sweats, weakness, fatigue, intermittent fever and increased pain at night which could indicate a systemic problem. Physical therapists should be aware that Ewing’s Sarcoma can mimic musculoskeletal signs and symptoms which can make it difficult to diagnosis. It is imperative to monitor the patient and refer out to patient’s MD when appropriate to prevent further metastasis of the tumor. The pelvic and hip region is the most common area affected by Ewing’s Sarcoma and can be difficult to observe and palpate due to its location. In this case the pt did not improve upon multiple visits which would indicate it is not a musculoskeletal pathology and the pt. was referred to her primary care provider for further testing.
== References ==
 
<references />
== Related Pages  ==
 
<br>Halwai MA, Mir BA, Wani MM, Bashir A, Hussain A. Ewing's sarcoma of the ilium mimicking inflammatory arthritis of the hip: a case report. Cases Journal. 2009;2(1):6487. doi:10.4076/1757-1626-2-6487. http://casesjournal.biomedcentral.com/articles/10.4076/1757-1626-2-6487&nbsp;<ref name="18">Halwai MA, Mir BA, Wani MM, Bashir A, Hussain A. Ewing's sarcoma of the ilium mimicking inflammatory arthritis of the hip: a case report. Cases Journal. http://casesjournal.biomedcentral.com/articles/10.4076/1757-1626-2-6487. Published June 29, 2009.</ref><br>
 
Park DY, Batista E, Rinsky LA. Ewing’s Sarcoma of the Humerus in a Three year-old boy Requiring Radical En-Bloc resection and Total Humeral Expandable Prosthetic Replacement: A Case Report. Surgery: Current Research. https://www.omicsonline.org/ewings-sarcoma-of-the-humerus-in-a-three-year-old-boy-requiring-radical-en-bloc-resection-and-total-humeral-expandable-prosthetic-replacement-a-case-report-2161-1076.1000101.pdf. Published September 2011&nbsp;<ref name="15">Park DY, Batista E, Rinsky LA. Ewing’s Sarcoma of the Humerus in a Three year-old boy Requiring Radical En-Bloc resection and Total Humeral Expandable Prosthetic Replacement: A Case Report. Surgery: Current Research. https://www.omicsonline.org/ewings-sarcoma-of-the-humerus-in-a-three-year-old-boy-requiring-radical-en-bloc-resection-and-total-humeral-expandable-prosthetic-replacement-a-case-report-2161-1076.1000101.pdf. Published September 2011</ref>
 
== Resources <br>  ==
 
== Recent Related Research (from &lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/"&gt;Pubmed&lt;/a&gt;)  ==
 
see tutorial on &lt;a href="Adding PubMed Feed"&gt;Adding PubMed Feed&lt;/a&gt;
<div class="researchbox">
<span>http://eutils.ncbi.nlm.nih.gov/entrez/eutils/erss.cgi?rss_guid=1fK6RBI2YOGLyVGF8mcgRy2PGF2FfeCz2pzb5We2STqBuqGsSa|charset=UTF-8|short|max=10</span>
</div>  
== References  ==


<references />
[[Category:Primary Contact]]
[[Category:Oncology]]

Latest revision as of 07:15, 27 January 2023

Introduction[edit | edit source]

Ewing-sarcoma-distal-femur

Ewing’s Sarcoma (ES) is the second highest grade malignant primary tumour of childhood and adolescence between 10-20 years of age, and can arise in soft tissue or bone. [1] ESs typically are found in the medullary cavity, appearing as moth-eaten, destructive lesions in the shaft of long bones, and onion skin periostitis.[2] The most common sites are the pelvis, axial skeleton, and femur, but they may occur in almost any bone or soft tissue. Patients with ES within distal extremities have a better prognosis than patients having a lesion in proximal extremities.[3]

Locations:

  1. Lower limbs: 45%(femur most common)
  2. Pelvis: 20%
  3. Upper limbs: 13%
  4. Spine and ribs: 13%(sacrococcygeal)
  5. Skull/face: 2%[4].

Epidemiolgy[edit | edit source]

Ewing sarcoma account for less than 5% of all soft tissue sarcomas.[3] ES usually appears in children and adolescents between 10-20 years of age (with 95% being between 4-25 years of age).Males are more affected than females (M:F 1.5:1).[2] The ES family of tumours primarily occurs in White patients. In the United States, the incidence in the Asian/Pacific Islander population is about one-half that in the White population, while the incidence in the Black population is one-ninth that in White population. [5] The incidence of Ewing’s Sarcoma has relatively been unchanged for the past 30 years and occurs  2.93 children per 1 million in the United States. [6].

Etiology[edit | edit source]

The cell of origin of Ewing sarcoma has yet to be fully explained[3]. It has been found that 95% of Ewing's tumours are derived from a specific reciprocal translocation between chromosomes 11 and 22. The molecular oncogenesis remains unknown[7][1].

Prognosis[edit | edit source]

Once a uniformly fatal tumour now has better survival rates, although these differ with location. eg Spinal tumours having an 86% long-term survival compared to 25% of sacrococcygeal tumours. Overall the 5-year survival rate is roughly 50-75% for patients with local disease only at the time of presentation.[2]

Characteristics/Clinical Presentation[edit | edit source]

Occasionally a soft tissue mass is palpable

Local pain at the affected site is usually the initial symptom[1]. The pain may be worse during exercise or at night and can be accompanied by swelling or a lump, redness, and warmth (see in this picture swelling of the left side)[8]. The pain is typically intermittent and ma progress to be more consistent.[9] Tumours that are deep inside the body such as the pelvis can be hidden from observation and inspection.

It is common to see fatigue, weight loss, decreased appetite, weakness and numbness, and/or paralysis or Urinary Incontinence (if the tumour is of spinal origin)[10]. Fever, anaemia, and leukocytosis may occur with this tumour and a palpable mass may present. The tumour may be present for months before there are any signs or symptoms. Symptoms can vary from patient to patient in terms of severity and can disappear from weeks to months at a time[4] Insufficiency Fractures also occur.[7]. Systemic symptoms include ESR elevation. Ewing's Family of Tumors are highly malignant. It most commonly spreads to the lungs, but it can also metastasize to the kidney, bone marrow, heart, adrenal gland, and other soft tissues[10].
As a physical therapist, one should be cautious when the symptoms of "growing pains" or a proposed sports injury are out of proportion or abnormal.

Differential Diagnosis[edit | edit source]

Diagnosis[edit | edit source]

Periostitis and soft tissue swelling.

The diagnosing Ewing’s Sarcoma depends on full patient history, symptoms and clinical presentation. X-rays of the affected area may show destructive confluent '' moth-eaten" lesions, an elevated periosteum, or multilayered "onion-skin" periosteal reaction.

Other tests that may be performed to rule in Ewing’s Sarcoma and determine staging are bone scans, CT scans, MRI, blood tests (elevated lactate dehydrogenase and red blood cell sedimentation rate) and biopsy for bone marrow, for example, to know whether it spreads to bone marrow or not. These tests in combination are important to find the location of the tumour and to determine if the tumour is localized or has diffused to other areas of the body to help guide treatment. Biopsy is considered the gold standard test for diagnosis of Ewing’s Sarcoma.[1][9][10]

Differential Diagnosis[edit | edit source]

Medical Management[edit | edit source]

Systemic chemotherapy is the central part of treatment with surgery and/or radiotherapy having a role depending on the size and location of the tumour. Medical management is considered a multidisciplinary effort which includes orthopaedic surgical oncologists, pediatric or adult medical oncologists, radiation oncologists, pathologists, and radiologists. Most patients are treated at major hospital institutions or cancer centres.[11][10][1][7]

Physical Therapy Management[edit | edit source]

Physical therapy (PT) can be beneficial for those diagnosed with ES for many reasons and at different stages during the management process. The most common limitations for patients undergoing chemotherapy include fatigue, paralysis, or weakness, cognition, and weight loss/ gain [9]
Pre-operative PT is beneficial when feasible. Plan of care should include strengthening of the affected limb and aerobic conditioning (precaution: avoid weight bearing on an extremity or placing weight distal to the extremity in which tumour is located).[4]
Post-operative PT is essential but caution must be taken because of the impaired healing process due to chemotherapy. Precautions include: stretching the skin in the area of the incision, weight-bearing status and lab values (especially platelet count). Some general guidelines include aerobic conditioning, strengthening, continuous passive range of motion, and aquatic therapy[4]. Research suggests that knowledge on the changes occurring in muscle architecture and its impact on long-term impairments in bone sarcoma survivors after limb salvage surgery can impact rehabilitation treatment outcomes[12].
If amputation is done, it may take the child several months to learn to use a prosthetic leg or arm. A physical therapist will be able to assist in fitting and donning the prosthesis, teaching the child how to use it, and how to use necessary assistive devices. Children may also have a tissue graft, which the child needs to start moving almost immediately. Physical therapy and rehabilitation is typically recommended for six to twelve weeks post operation[7].

Watch this 2 minute video on PT management
                                    

[13]

Ewing’s Sarcoma Case Study[edit | edit source]

Keywords

Fatigue, treatment, fever, bone pain, cancer, therapy, symptoms
Authors

Jack Tencza and Joseph Dorrell
Abstract

Ewing’s Sarcoma is the 2nd most commonly diagnosed form of primary bone cancer in children and young adults. In this example, a case study of an 18 year old Caucasian female gymnast is examined to help health care professionals identify a possible clinical case of Ewing’s Sarcoma.
Introduction

Ewing’s Sarcoma family of tumours are a group of small round cell tumours that include Ewing’s Sarcoma, Extraosseous Ewing Sarcoma, Askin Tumor, and Primitive Neuroectodermal Tumor. This cancer primarily affects children and adolescents, and most often affects soft tissue and bone. The most common sites for Ewing’s Sarcoma is the pelvis, hip, femur, tibia and fibula.

Case Presentation[edit | edit source]

Subjective :
Patient History: Pt. is an 18-year old Caucasian female who reports with a recent history of right hip pain of 5/10 during the day and 7/10 at night. She reports limping from a cartwheel at gymnastics 2 months ago. She reports that she has had night sweats with intermittent fever and general fatigue during the day. Pt. reports that she has had a recent physical examination 5 months ago with her GP who found that she was underweight. GP states this could be possibly due to female athlete triad. She notes that she has been more attentive with her diet and exercise since then. Pt. states her goal is to return to gymnastics pain-free and as soon as possible.

Medical History: Unremarkable
Objective-: Physical Examination Tests and Measures

Observation/ Palpation: Pt. has to pinpoint tenderness around R ASIS, and notes pain with R weight shifting
Lumbar ROM
Lumbar Flexion 65
Lumbar Extension 35
Lumbar Side bend 20
Lumbar Rotation 30

Hip ROM Right Left
Hip Flexion     85 130
Hip Extension 15 30
Hip IR            20 40
Hip ER          25 40
Hip ABD       25 45

MMT
L Hip 5/5 in all planes
R Hip 4/5 in all planes (pain)
UE ROM: WNL
UE MMT: WNL


Neurovascular: decreased sensation along R lateral thigh
Special Tests:
FABER - Negative
Scour Test - Positive
Anterior Labral Tear - Negative
Impingement Test - Positive

Clinical Impression

Examination findings show decreased ROM and weakness of the R hip with palpable pinpoint pain, tenderness, and warmth. No other musculoskeletal abnormalities found to be present. Working diagnosis of female athlete triad and hip impingement. Targeted interventions include strengthening the R hip musculature, improving R hip ROM in all planes, manual therapy to decrease pain and improve function, and modalities for pain relief.

Intervention

Hip AROM/ PROM exercises
Standing hip flexion, extension, abduction, IR and ER resistance exercises
Wall slides & standing squats
Hip long axis traction

Outcomes

Over a period of 5 visits, pt’s s/s did not improve. the Pain intensified to a 7/10 during the day and an 8/10 at night. PT then determined that pt needed to be referred out for imaging of the hip. Pt went to MD and received X-Ray which indicated a possible tumour of the pelvis. Blood tests indicated elevated lactate dehydrogenase and red blood cell sedimentation rate. MD referred to Oncologist for a biopsy which confirmed an Ewing’s Sarcoma of the pelvis. Pt received chemotherapy and radiation.


Discussion

Ewing’s Sarcoma is a malignant bone tumour which in this case affects a female, which is not as common as a male. In this case, the pt. demonstrated constitutional signs and symptoms including night sweats, weakness, fatigue, intermittent fever and increased pain at night which could indicate a systemic problem. Physical therapists should be aware that Ewing’s Sarcoma can mimic musculoskeletal signs and symptoms which can make it difficult to diagnosis. It is imperative to monitor the patient and refer out to patient’s MD when appropriate to prevent further metastasis of the tumour. The pelvic and hip region is the most common area affected by Ewing’s Sarcoma and can be difficult to observe and palpate due to its location. In this case the pt did not improve upon multiple visits which would indicate it is not a musculoskeletal pathology and the pt. was referred to her primary care provider for further testing.

References[edit | edit source]

  1. 1.0 1.1 1.2 1.3 1.4 Paulussen, Michael. Frohlich, Brigit, Jurgens, Herbert. Ewing Tumour: Incidence, Prognosis, and Treatment Options. Pediatric Drugs 2001; 3(12); 899-913.(accessed 28 Feb 2011).
  2. 2.0 2.1 2.2 2.3 2.4 Radiopedia Ewing sarcoma Available:https://radiopaedia.org/articles/ewing-sarcoma?lang=gb (accessed 27.12.2023)
  3. 3.0 3.1 3.2 Durer S, Shaikh H. Ewing sarcoma.Available: https://www.ncbi.nlm.nih.gov/books/NBK559183/(accessed 267.1.2023)
  4. 4.0 4.1 4.2 4.3 Ewing sarcoma. Bone Cancer Research Trust. Accessed April 5, 2017.
  5. Burningham Z, Hashibe M, Spector L, Schiffman JD. The epidemiology of sarcoma. Clinical sarcoma research. 2012 Dec 1;2(1):14.
  6. Ewing’s SarcomaTreatment. National Cancer Institute. https://www.cancer.gov/types/bone/hp/ewing-treatment-pdq#link/_153_toc.
  7. 7.0 7.1 7.2 7.3 Goodman, Boissonnault, Fuller. Pathology: Implications for the Physical Therapist. Pennsylvania: Saunders, 2003.
  8. Medline Plus. Ewing’s Sarcoma. http://www.nlm.nih.gov/medlineplus/ency/article/001302.htm (accessed Feb 2011).
  9. 9.0 9.1 9.2 Elaine Lonnemann’s Powerpoint, Oncology. Pathophysiology of Complex Patient Problems. Bellarmine University 2011.
  10. 10.0 10.1 10.2 10.3 Gerrand C, Athanasou N, Brennan B, Grimer R, Judson I, Morland B, Peake D, Seddon B, Whelan J. UK guidelines for the management of bone sarcomas. Clinical Sarcoma Research. 2016 Dec 1;6(1):7.
  11. Bouaoud J, Temam S, Cozic N, Galmiche‐Rolland L, Belhous K, Kolb F, Bidault F, Bolle S, Dumont S, Laurence V, Plantaz D. Ewing’s Sarcoma of the Head and Neck: Margins are not just for surgeons. Cancer medicine. 2018 Dec;7(12):5879-88.
  12. Nelson CM, Marchese V, Rock K, Henshaw RM, Addison O. Alterations in muscle architecture: A review of the relevance to individuals after limb salvage surgery for bone sarcoma. Frontiers in Pediatrics. 2020;8.
  13. Joseph Dorrell. Physiopedia Ewing's Sarcoma PT Management. Available from: http://www.youtube.com/watch?v=FRcrAieE_TA[last accessed 25/7/2020]